FDA Grants Approval for Bupivacaine Hydrochloride by Anthea Pharma
The FDA has granted approval for Bupivacaine Hydrochloride under application ANDA220493 submitted by Anthea Pharma.
Company
Pharmaceutical intelligence for Anthea Pharma with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.